Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEX010 for Opioid Use Disorder
NCT06608459Phase 2Not yet recruiting
- Start
- Dec 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of PEX010 in opioid use disorder (OUD). Planned start Dec 2024; status: not yet recruiting.
02
Drugs
PEX010
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT06608459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06608459.